IL17A and myeloid sarcoma: Additionally, the use of cannabinoids such as THC and CBD in MS treatment may suppress Th17—which is frequently elevated in patients with inflammatory autoimmune disorders like MS—by reducing the synthesis and secretion of IL-17 [161,162].